Get to know biosimilars
Developing Biosimilars: from innovator biologics to biosimilar medicine
Learn more
Developing the totality of evidence for biosimilars: regulatory considerations for the healthcare community
substitution and interchangeability
Distinct therapeutic choices
Learn more
Substitution and interchangeability: Defining the terms
Learn more
Current Canadian landscape on biosimilar naming
Learn more
there is broad support
for distinguishable
names for biosimilars
Learn more
substitution and interchangeability
interchangeability and substitution
worldwide
View map
How Health Canada
defines
interchangeability
Learn more